Homozygous deletion of the CDKN2A/B gene was detected in a larger proportion of the glioblastoma IDH-wildtype tumors (9/15) compared to glioma IDH-mutant tumors (9/106) (Fisher’s exact test p value < 0.001). The gene discussed is CDKN2A; the disease is glioma.